View topic - NorBAC Emails

unforum
a.r.g.b.b

Welcome!

New users, PLEASE read these forum guidelines. New posters, SEARCH before posting and read these rules before posting your killer new campaign. New players may also wish to peruse the ARG Player Tutorial.

All users must abide by the Terms of Service.

Website Restoration Project

This archiving project is a collaboration between Unfiction and Sean Stacey (SpaceBass), Brian Enigma (BrianEnigma), and Laura E. Hall (lehall) with
the Center for Immersive Arts.

Announcements

This is a static snapshot of the
Unfiction forums, as of
July 23, 2017.

This site is intended as an archive to chronicle the history of Alternate Reality Games.

Our Esteemed Contributors

The time now is Tue Nov 12, 2024 12:52 am
All times are UTC - 4 (DST in action)

View posts in this forum since last visit
View unanswered posts in this forum

Calendar

Forum index » Archive » Archive: General » ARG: Regenesis

NorBAC Emails

Page 1 of 1 [4 Posts]

Author

Message

Buck Rodgers12
Veteran

Joined: 27 Sep 2004
Posts: 124
Location: Los Angeles

NorBAC Emails

Quote:

From: newsletter@norbac.ca Add to Address BookAdd to Address Book
To: btuverson@yahoo.com
Subject: NorBAC Press Release #4
Date: Mon, 25 Oct 2004 01:10:04 -0400

ALERT: UNIDENTIFIED INFECTIOUS AGENT

The North American Biotechnology Advisory Commission (NorBAC) confirms
the existence of an unidentified infectious agent in Northern Ontario,
Canada.

There is no risk for the general population at this time and there are
no travel advisories or restrictions. However NorBAC advises all
visitors and residents in the area along Highway 17 to be diligent about
thorough hand-washing and to seek immediate medical attention if any of the
following symptoms are experienced: high temperature, persistent
headache, pox, spontaneous bleeding, fainting, weakness, or loss of
consciousness.

NorBAC is currently working with several international health
organizations, national disease centres, and noted experts on hemorrhagic fevers
and poxes.

Progress has been made in the medical investigation; however we urge
any clinicians or researchers with knowledge or insight into a possible
Camelpox and Ebola chimera (or hybrid) virus to immediately contact
tiplineSPLATnorbac.ca.

The scientific investigation is being headed by: Dr David Sandstr�m,
NorBAC's Chief Scientist

And the following lead investigators:
Biochemistry: Dr Robert Melnikov
Bioinformatics: Dr Mayko Tran.
Pathology: Dr Carlos Serrano
Virology: Dr Hira Khan

Caroline Morrison, JD, Executive Director of the NorBAC Laboratory in
Toronto, is spearheading the coordination of NorBAC's scientific
investigation with other health, safety, and regulatory agencies.

Quote:

From: newsletter@norbac.ca Add to Address BookAdd to Address Book
To: btuverson@yahoo.com
Subject: NorBAC Press Release #5
Date: Mon, 25 Oct 2004 01:10:04 -0400

UPDATE: Virus Identified

The North American Biotechnology Advisory Commission (NorBAC) has
identified Northern Ontario's infectious agent as a human-made, synthesized
hybrid of Camelpox and Ebola.

This chimera or hybrid virus remains extremely dangerous and infects by
airborne contact. It penetrates blood cells and causes them to erupt
after a short incubation period. Typical symptoms include the bleeding of
orifices such as the eyes, ears, nose, mouth and rectum.

However, there is no immediate cause for concern. All known carriers of
the virus are in quarantine and will remain there until the viral
incubation period has passed.

Health officials continue to remind Ontario residents that washing the
hands is the best way to prevent exposure to infection. Anyone who
believes he or she has come in contact with the Camelpox/Ebola hybrid is
asked to remain isolated from all human contact and seek immediate
emergency medical attention.

Several fatalities have already resulted from this week's outbreak,
though official numbers will be released only upon completion of pathology
tests at NorBAC Laboratories. Currently 234 people remain in quarantine
in Toronto.

The genetic sequence of the CP-EB chimera virus remains available to
registered institutional subscribers through the NorBAC Intranet. We
further request that all expert molecular biologists specializing in siRNA
send their CV to Weston Field for possible future collaboration,
secondment, or employment.

Dr David Sandstr�m, NorBAC's Chief Scientist, is currently on
assignment and is unavailable. Dr Carlos Serrano is acting Chief Scientist until
further notice.

Quote:

To: btuverson@yahoo.com
Subject: NorBAC Press Release #7
From: newsletter@norbac.ca Add to Address BookAdd to Address Book
Date: Sun, 31 Oct 2004 21:50:19 -0500 (EST)

NorBAC Scientist Slain at Protest Rally

The North American Biotechnology Advisory Commission deeply regrets to
announce the loss of Dr. Hira Khan, Head of Virology in Toronto,
Canada.

Dr. Khan was fatally shot by an unknown assailant outside the NorBAC
laboratory in Toronto on October 22, during a rally held by a religious
organization called The Second Coming Project.

"A diligent scientist, trusted colleague and personal friend to many,
Dr. Khan will be greatly missed at the NorBAC laboratory," said NorBAC
Executive Director Caroline Morrison. A scholarship fund is being set up
in Dr. Khan's name in connection with the University of Toronto Medical
School, to aid students from the developing world.

Internationally recognized for her work in the field of virology, Dr.
Khan immigrated to Canada from Lahore, Pakistan with her family at the
age of 7. Her ground-breaking post-doctoral work at the Institute of
Human Virology, in Maryland, USA, furthered study in the development of
monoclonal antibodies, which are used for the detection of cancer
antigens and in cancer immunotherapy.

Dr. Khan completed her undergraduate work at the University of Toronto
and earned her doctorate at the University of Cambridge. She worked in
the Department of Virology at the United States Defense Labs at Fort
Egan, from 1996 to 2001, and went on to teach Infectious Diseases at the
University of Karachi Medical School, 2001 to 2003, before coming to
NorBAC.

Dr. Khan's assailant is currently being held in police custody in
Toronto. Officials describe the man as mentally unstable and believe he may
have been attempting to assassinate NorBAC's Chief Scientist, Dr David
Sandstr�m, but mistakenly struck Dr. Khan instead.

The attack occurred during a rally of The Second Coming Project, an
organization that claims it is currently cloning Jesus Christ from a blood
sample found on an ancient artifact. Reverend Stephen Walsh, director
of The Second Coming Project, wanted NorBAC to study the relic and
substantiate their claim.

Dr David Sandstr�m has categorically denied any connection between
himself, NorBAC Laboratories, Reverend Walsh and The Second Coming Project.

Quote:

To: btuverson@yahoo.com
Subject: NorBAC Press Release #6
From: newsletter@norbac.ca Add to Address BookAdd to Address Book
Date: Sun, 31 Oct 2004 23:15:09 -0500 (EST)

URGENT: TO ALL MEDICAL PRACTITIONERS AND SCIENTIFIC INVESTIGATORS

UPDATE: Virus Identified

Patient Zero of the Camelpox/Ebola hybrid virus has been identified as
Miranda M., an infant, who passed away overnight due to complications
from her infection.

Security and police officials in Canada, Mexico and the United States
have been notified of the discovery, made yesterday by the North
American Biotechnology Advisory Commission (NorBAC). British intelligence
officials and Interpol's General Secretariat in Lyon, France, have been
further informed that a Martin Jamison, traveling under a stolen UK
passport in the name of William Zanzinger, is wanted for questioning.

Bio-terrorism has neither been confirmed nor ruled out in the case by
NorBAC Executive Director Caroline Morrison. Martin Jamison may be an
alias. He is considered extremely dangerous. His last known address is
332 Shaftesbury Lane, London, WC2H 8EG. Anyone with information on Martin
Jamison, his whereabouts, or any information that may lead to his
arrest, please contact tiplineSPLATnorbac.ca.

Currently, concerns throughout the country regarding the Camelpox/Ebola
virus have been alleviated by the identification of Miranda M. as
Patient Zero. All known reports from the Ontario Ministry of Health continue
to confirm that no further infections have occurred since the
quarantining of Patient Zero in Toronto on October 24.

However, Ontario residents are still urged to maintain high standards
of personal hygiene and isolate themselves from family, friends and
coworkers if suffering from any of the following symptoms: persistent
headaches, high temperature, skin blisters, weakness or loss of
consciousness.

Of the 234 citizens who have been infected and quarantined, none will
be identified until their friends and family members are officially
contacted by NorBAC or the Ministry of Health. Analysis of quarantined
citizens is currently aiding NorBAC scientists in their search for a
vaccine to the human-made virus. Initial reports indicate that a solution may
be available once the design of the virus has been fully investigated.

Therefore we continue to recommend that all area residents remain calm
and follow regular updates from the Ministry of Health and NorBAC.

Quote:

NorBAC Chief Scientist Dismisses Christ Claim

NorBAC Chief Scientist Dr. David Sandstr�m has dismissed the claim of a national religious organization that maintains it is currently cloning Jesus Christ.

According to Dr. Sandstr�m, The Second Coming Project, based in Toronto, cannot clone Jesus with an ancient blood sample for several reasons, including:

- The cloning of mammals poses numerous scientific difficulties, and no one has successfully cloned a human being, even under ideal scientific conditions
- No coherent DNA code can be drawn from a 2,000-year-old blood sample unless it has been perfectly preserved (in amber or ice, for example)
- Even if it were possible to fill in the gaps of degraded DNA with donor DNA, the result would not be a clone but a genetically unique individual, called offspring

Dr. Sandstr�m further rejected the scientific arguments of Reverend Stephen Walsh, director of The Second Coming Project, as insubstantial on the grounds that:

- Rev. Walsh's claim that he has obtained a sample of Christ's blood from an authentic crucifixion nail cannot be proved. Even if metallurgists have confirmed the nail's date and use by the Roman Empire in ancient Palestine, as Rev. Walsh maintains, there is no proof that the nail was used to crucify Jesus
- The fact that scientists have identified the blood on the nail as Semitic is also insignificant, said Dr. Sandstr�m, since many other Semites were crucified by the Romans during that period
- Dr. Sandstr�m further dismissed the claim that the nail's blood has been preserved by a process the reverend calls "divine coagulation." No such process is known to exist

"Rev. Walsh says his DNA sample matches a vial of Christ's blood found in a Belgian chapel -- a claim that is frankly beneath serious criticism," Dr. Sandstr�m said. "And if I were Walsh, I would wait until human cloning were scientifically established before trying it out on Our Lord."

On Oct. 31, NorBAC Head of Virology Dr. Hira Khan was fatally shot during a rally held by The Second Coming Project outside NorBAC's laboratory in Toronto. Her assailant was apprehended by authorities but remains unidentified.
-----
NorBAC is a scientific organization that maintains no official position on articles of faith, religion or spirituality.

Quote:

URGENT: TO ALL MEDICAL PRACTITIONERS AND SCIENTIFIC INVESTIGATORS
ALERT: PRION DISEASE

NorBAC has opened an investigation into a recent outbreak of the fatal, brain-degenerative disease Spongioform Encephalopathy (or Prion Disease) in Florida, Texas and Southern California. Only four victims have been identified so far but all contracted the disease and died in a period of days; Prion Disease normally takes seven to eight years to fully affect the brain.

All four victims experienced no serious health problems until contracting the disease last week. Reuben de la Pena, 22, of Austin, Texas; Maurice White, 52, of San Antonio, Texas; Martin Crutchfield, 72, of Santa Barbara, California; and Sara McKinley, 5, of Tampa, Florida, have all contracted Prion Disease from an unknown source.

Scientists have no explanation for the victims' accelerated decline, but said they may be rare cases which possess a transporter gene that passes mutant prions through the blood-brain barrier at a faster rate.

Prion Disease has no known cure and is eventually fatal. Its variants include Creutzfeld-Jakob or "Mad Cow" disease in cattle and Scrapie in sheep. In humans, symptoms include memory loss, erratic behaviour, lack of coordination, inability to walk and rapid death.

Originally called Kuru or "laughing sickness," the disease was discovered in 1957 in Papua New Guinea, where residents acquired the sickness through ritual cannibalism. American neurologist Stanley Prusiner won the Nobel Prize in 1997 for postulating that the disease was caused by particles that contain no genetic material and are made entirely of protein, which he called prions. However, Prusiner's findings still lack consensus in the scientific community.

We urge doctors and health professionals who believe they are presented with a case of Spongioform Encephalopathy to contact NorBAC at the earliest possible opportunity at tiplineSPLATnorbac.ca.

The genetic sequence of the Prion Disease protein is available to registered institutional subscribers through the NorBAC Intranet.

Quote:

NorBAC Seeks Experienced Virologist

The North American Biotechnology Advisory Commission is seeking a permanent, full-time scientist with demonstrated expertise in virology, to serve as senior researcher investigating viral agents. Under the supervision of Chief Scientist Dr. David Sandstr�m, the incumbent will oversee several aspects of the laboratory's virological research, and be asked to organize, conduct and report original research that combines diagnostics with strategies for virus prevention.

NorBAC prefers candidates with knowledge and experience in microbial pathogenesis mechanisms; knowledge/experience of microbial genotyping, developing in vitro or in vivo models/assays to analyze host-parasite interactions and microarray technologies is also desired. The virology research position will involve exposure to a wide variety of genomics technologies in a modern facility, where novel SNP discovery and large-scale Comparative Genome Hybridization(CGH) studies will be performed.

Job duties may include the development of countermeasures against highly toxic materials. All candidates must be ready to study highly hazardous biological materials in a BSL-3 laboratory, perform standard microbiological procedures and immunological assays such as ELISA, TNA, plaque and plaque reduction neutralization assays, support and conduct in vivo pathogenicity/toxicity studies, and decontaminate equipment and materials.

Candidates must be Canadian, U.S. or Mexican citizens. Candidates must also be willing to be immunized with licensed and FDA approved IND, and participate in periodic drug screening.

Education: Ph.D. in Microbiology or related biomedical field with minimum 5 years experience in virology. Candidates should also have a publication record in one or more of the following areas: virus replication strategies, viral genetics, oncogenic viruses, human immunodeficiency virus, development of viral vaccines, virus-host interactions, influenza virus or any major area of modern virology.

Candidates are asked to please send CV and a minimum of three published papers to PO Box 336, Station B, Toronto Canada M5T 2W2.

Quote:

URGENT: TO ALL MEDICAL PRACTITIONERS AND SCIENTIFIC INVESTIGATORS

UPDATE: Prion Etiology Identified

US Congresswoman Patricia Schuler, the Chair of the NorBAC Trilateral Committee, is pleased to announce that Wide Valley Farms will voluntarily depopulate six million bird, totaling 24.2 million pounds, out of consideration for the public health.

The move comes as a result of a recent investigation by NorBAC of an outbreak of Spongioform Encephalopathy in the South and Southwestern United States.

Congresswoman Schuler asserts that the action by Wide Valley Farms will make a significant contribution to eradicating Spongioform Encephalopathy, and restore a high level of confidence among American poultry consumers.

Human prions, which cause the brain-degenerating disease Spongioform Encephalopathy (or Prion Disease), were found in chickens at two Wide Valley Farms operations.

"However, Wide Valley Farms wanted to eliminate any potential risk, even if that meant closing down a third, nearby farm," said Congresswoman Schuler. "Their attitude, like ours, is and always has been zero tolerance when it comes to any risk to the public health."

Concern was recently aroused after Centers for Disease Control and Prevention and NorBAC investigated four cases of Prion Disease. Reuben de la Pena, 22, of Austin, Texas; Maurice White, 52, of San Antonio, Texas; Martin Crutchfield, 72, of Santa Barbara, California; and Sara McKinley, 5, of Tampa, Florida, all contracted the disease from an unknown source and died only days later. Normally Prion Disease takes seven to eight years to fully affect the brain.

Prion Disease has no known cure and is eventually fatal. Its variants include Creutzfeld-Jakob or "Mad Cow" disease in cattle and Scrapie in sheep. In humans, symptoms include memory loss, erratic behaviour, lack of coordination, inability to walk and rapid death.

The U.S. poultry industry currently employs an estimated 500,000 people.

Quote:

NorBAC Warns Muscle Growth Hormones Can Be Fatal

In the wake of three recent deaths among professional hockey players, the North American Biotechnology Advisory Commission is cautioning athletes and body builders against using muscle growth hormones that may go undetected by modern drug testing.

Hockey players Marty Birilski, 24, and Denis Archambault, 32, recently died of heart attacks while playing, and minor league veteran Danny Dexter, 38, called up from the Eastern Coast League, died after testing positive to an obscure muscle growth hormone.

Tests of Dexter's blood showed that he had taken a mutated version of a skeletal muscle growth hormone made by the Italian company GenoaQuest. Glycosylation patterns suggested that the hormone was not produced in a test tube, but was synthesized in his own cells � meaning that he took an injection of DNA that caused his body to create its own independent growth hormone.

"Instead of injecting something into him that he's not supposed to have, he got his body to make it for him," said Norbac Chief Scientist Dr. David Sandstr�m. "It's very difficult to detect and acts directly on muscles, including the heart muscle, causing it to explode."
Anabolic steroids and growth hormones are believed to be common among professional athletes, although in professional hockey, as in baseball, there is only limited testing. Baseball recently discovered that between five and seven percent of its players tested positive for steroids. The National Football League, warned of regular steroid use among its players, now tests them extensively.
Although statistics vary, one national U.S. survey found that 3.5 percent of high school seniors also admitted to using steroids at least once � a 67 percent increase from 1991 and 17 percent from 1999, according to the National Institute on Drug Abuse.
The health effects of steroids have been debated for several years, but a 2003 Finnish study suggests that a mixture of steroids and growth hormone can cause serious ventricular hypertrophy, or heart damage.

NorBAC urges all athletes and bodybuilders, whether amateur or professional, to rely on their own natural growth hormones and stay away from drugs that could shorten their careers or even their lives

Now i know they're all over the forums, but i just thought it would be easier and cleaner to put them all here.

_________________
Pandora Next!

Media Team Member: The Architect

Mission Statement: TBA

Posted: Sun Nov 21, 2004 7:40 pm

Buck Rodgers12
Veteran

Joined: 27 Sep 2004
Posts: 124
Location: Los Angeles

Quote:

NORBAC HIRES NEW VIROLOGIST

The North American Biotechnology Advisory Commission (NorBAC) is pleased to announce the hiring of Dr. Jill Langston, new Head of Virology at the NorBAC Laboratory in Toronto. An internationally-recognized expert on the Spanish Flu, Dr Langston has extensive polar field experience in archaeo-virology and has taught at several major universities in Europe and the US.

She completed her undergraduate degree in molecular biology from Princeton and pursued her doctorate in virology at Stanford with the late Dr. Alphonso Garlichieri.

In a recent study as Assistant Professor of Virology at MIT, Dr. Langston extracted DNA from a Spanish Flu victim buried north of the permafrost line in Greenland, and successfully sequenced the fourth of eight segments of the victim's viral DNA. Her findings are to be published in the Journal of Virology, Dec. 2004.

Dr. Langston has produced work on subjects such as the cellular and humoral immune-responses to viral-antigens, immediate early transcription responses to hepatitis C infection of macrophages, and the identification and the divergence of mRNA targets for Ssb proteins. She has been published in such scientific journals as World Journal of Microbiology, Biotechnology and Frontiers In Bioscience and Infectious Disease News.

Dr. Langston has also acted as visiting scientist at the Ivanovski Institute of Virology, Moscow, 1992; Universit� Pierre et Marie Curie, Paris, 1997-98; University of California, Davis, 2000; and University of Connecticut, Storrs, 2002.

Her scholarships and awards include:

* Distinction in Virology at Princeton University
* JCSMR Gordon Ada PhD Scholarship in Immunology or Virology
* PASCV Clinical Virology Award
* Listed in Who's Who of Emerging Leaders in America

Dr. Langston is a standing member on several medical committees worldwide, including the International Committee on Taxonomy of Viruses and the ATCC Advisory Committee for the American Society of Virology.

Dr. Langston will replace the late Dr. Hira Khan, former head of virology for NorBAC.

_________________
Pandora Next!

Media Team Member: The Architect

Mission Statement: TBA

Posted: Mon Nov 22, 2004 9:23 pm

Buck Rodgers12
Veteran

Joined: 27 Sep 2004
Posts: 124
Location: Los Angeles

Quote:

NORBAC CONFIRMS APPROVAL OF APLIEX LEUKEMIA TREATMENT

After further review of an experimental gene therapy treatment for Acute Myelogenous Leukemia (AML), the North American Biotechnology Advisory Commission (NorBAC) is pleased to announce that it again finds no conclusive statistical danger to treatment recipients.

NorBAC Chief Scientist Dr. David Sandstr�m has confirmed his approval of the treatment, finding NorBAC's initial study for the National Drug Trials Review Board (NDTRB) regarding the risk aspect of Apliex Pharmaceuticals' experimental gene therapy treatment (GT-57) for AML to be correct.

Tests conclusively showed that Justin Ricci, 7, lapsed into a coma during the GT-57 treatment last week due to an onset of blast crisis, a stage of AML in which large amounts of immature, abnormal white blood cells are produced by the bone marrow.

An earlier reported fatality, of Maxwell Peterson, 11, was also caused by factors unrelated to the treatment, according to Dr. Sandstr�m. Peterson passed away due to a condition called cytokine storm, known to occur in AML patients, in which the body creates a systemic _expression of multiple inflammatory mediators.

The GT-57 treatment, administered by Dr. Julius Booker of Toronto, has successfully eliminated the mutant protein in damaged cells of six patients and caused their AML to go into remission.

NorBAC extends its sympathies to the Ricci and Peterson families.

_________________
Pandora Next!

Media Team Member: The Architect

Mission Statement: TBA

Posted: Sun Nov 28, 2004 11:19 pm

Buck Rodgers12
Veteran

Joined: 27 Sep 2004
Posts: 124
Location: Los Angeles

Quote:

URGENT: TO ALL MEDICAL PRACTITIONERS AND SCIENTIFIC INVESTIGATORS

ALERT: NORBAC OPERATIONS MINIMIZED DURING BLACKOUT

Operations at the North American Biotechnology Advisory Commission (NorBAC) are currently minimized due to a power blackout that has affected the Northeastern United States and Canada.

NorBAC will continue to operate on a skeleton staff at its Toronto laboratory while allocating resources to an investigation of the blackout, in cooperation with CSIS, the FBI, ATF and the U.S. Department of Homeland Security. The cause of the blackout has not yet been determined, but there is currently no evidence of terrorism.

The source of the blackout is believed to be in the Buffalo, N.Y. area. Residents currently affected by the blackout are advised to remain calm and obtain or assemble an emergency kit containing:

* Radio
* Flashlights
* Batteries
* Copies of insurance and other important paperwork
* Bottled water
* Tinned food
* First aid kit

If bottled water cannot be found in sufficient quantity, you will find potable water in the upper tank of your toilet. Residents affected by the blackout are further advised to:

* Turn off all electrical appliances, but keep one light switch on to know when power returns
* Wear multiple layers of clothing to trap body heat, better than in one heavy layer
* Eat perishable foods before 36 hours without refrigeration
* Purchase foods which require no cooking, such as tinned meats, breads, vegetables and cereal

Anyone in need of medical service is advised to find the nearest emergency shelter or Red Cross as listed in the public telephone directory.

_________________
Pandora Next!

Media Team Member: The Architect

Mission Statement: TBA

Posted: Sat Dec 11, 2004 1:34 am

Display posts from previous: Sort by:

Page 1 of 1 [4 Posts]

Forum index » Archive » Archive: General » ARG: Regenesis

Jump to:

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum
You cannot attach files in this forum
You can download files in this forum
You cannot post calendar events in this forum